Skip to main content
- Onboarding Tools
- Team Charter
- Determining Cardiometabolic Program Goals and Aims
- Practice Needs Assessment
- Team Member Survey
- Care Team Workflow Assessment
- Building Teams and Optimizing Workflows
- Implementing Clinical Pharmacist Services
- Implementing Supplemental Services
- Continuous Quality Improvement
- Debriefing for Improvement
- Operational Resources
- Cardiometabolic Assessment Form
- Documentation Quick-Phrase Examples by Medication Class
- Frequent Contact List
- Manufacturer Contact List
- SBAR Template for Triaging Individuals with Diabetes
- Program Operation Best Practices for Medical Office Support
- Registry Management
- Registry and IT Assessment
- Documentation Quick-Phrase Examples by Medication Class
- CMCA Registry Initiation Process
- Performance Metrics Overview
- CMCA Guideline Directed Medical Therapy Pathways
- Optimal Cardiometabolic Therapy Pathways
- Selecting T2DM Medication for CV Risk Reduction
- Selecting Adjunct and Alternative Non-Statin Therapy for CV Risk Reduction
- Statin-Associated Muscle Symptom (SAMS) Mitigation Pathway
- SGLT2i
- Protocol for Use of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)
- Practical Implications for Use of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)
- What Your Patient Needs to Know: Starting a Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)
- Drug Class Overview: Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)
- GLP-1ra
- Protocol for Use of Glucagon-like Peptide-1 Receptor Agonists (GLP-1ra)
- Practical Implications for Use of Glucagon-like Peptide-1 Receptor Agonists (GLP-1ra)
- What Your Patient Needs to Know: Starting an Injectable Glucagon-like Peptide-1 Receptor Agonist (GLP-1ra)
- What Your Patient Needs to Know: Starting an Oral Glucagon-like Peptide-1 Receptor Agonist (GLP-1ra)
- Drug Class Overview: Glucagon-like Peptide-1 Receptor Agonists (GLP-1ra)
- ACE-I/ARB
- Protocol for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers (ACE-I/ARBs) in the Setting of ASCVD and T2DM
- Practical Implications for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers (ACE-I/ARBs) in the Setting of ASCVD and T2DM
- Drug Class Overview: Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in the Setting of ACVSD and T2DM
- Antiplatelets/Anticoagulants
- Protocol for Use of Oral Antithrombotic Agents (Antiplatelets and Anticoagulants)
- Practical Implications for Use of Oral Antithrombotic Agents (Antiplatelets and Anticoagulants)
- Drug Class Overview: Oral Antithrombotic Agents (Antiplatelets and Anticoagulants)
- Statins
- Protocol for Use of HMG-CoA Reductase Inhibitors (Statins) in the Setting of ASCVD and T2DM
- Practical Implications for Use of HMG-CoA Reductase Inhibitors (Statins) in the Setting of ASCVD and T2DM
- Drug Class Overview: HMG-CoA Reductase Inhibitors (Statins)
- PCSK9i
- Protocol for Use of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors (PCSK9i)
- Practical Implications for Use of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors (PCSK9i)
- What Your Patient Needs to Know: Starting a PCSK9i
- Drug Class Overview: Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors (PCSK9i)
- Insulin and Additional Oral Medication Resources
- Insulin and Insulin Secretagogues: Considerations When Initiating a New Glucose-Lowering Medication
- Protocol for Titration of Insulin and Insulin Secretagogues When Initiating a SGLT2i
- Protocol for Titration of Insulin and Insulin Secretagogues When Initiating a GLP-1ra
- Other Medications Commonly Used in Treating Cardiometabolic Patients
- Professional Society Standards, Guidelines, and Position Statements
- ACC-ADA Consensus Pathway for Cardiovascular Risk Reduction in Type 2 Diabetes 2020
- AACE-ACE Comprehensive Type 2 Diabetes Algorithm 2020
- ADA Standards of Medical Care in Diabetes 2021
- ESC-EASD Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases 2019
- ADA Diabetes and Hypertension Position Statement 2017
- ACC-AHA Versus ESC-ESH on Hypertension Guidelines 2019
- ACC-AHA Guideline for High Blood Pressure 2017
- ACC-AHA Guideline on the Management of Blood Cholesterol 2018
- ACC-AHA Guideline for Primary Prevention of CVD 2019
- ACC Consensus Pathway for Optimization of Heart Failure Treatment 2021
- AHA-HFSA Type 2 Diabetes Mellitus and Heart Failure Scientific Statement 2019
- ACC-AHA-HFSA Focused Update Guideline for Heart Failure 2017
- ACCF-AHA Guideline for Heart Failure 2013
- AHA Cardiorenal Protection With the Newer Antidiabetic Agents in Patients with DM and CKD 2020
- KDIGO Clinical Practice Guidelines for Diabetes Management in CKD 2020
- AACE-TOS-ASMBS-OMA-ASA Guidelines for Individuals Undergoing Bariatric Procedures 2019
- CDC Vaccine Information for Adults
- Disease Management Guides and Programs
- Living Well with Diabetes (ADA)
- Living with Diabetes (ACP): Low Literacy Resource
- Heart Guide (Mended Hearts)
- Healthier Living with Heart Failure (AHA)
- My Action Plan for Heart Failure (ACC)
- Living Well – Your Guide – Your Journey (OAC-ACP)
- Living with Type 2 Diabetes Program (ADA)
- National Diabetes Prevention Program (CDC)
- Your Weight Matters for Your Health (OAC)
- ASCVD
- Coronary Artery Disease (ACC)
- What is Angina (AHA)
- What is a Heart Attack (AHA)
- All About Stroke (ADA)
- What are Heart Disease and Stroke (AHA)
- What is Peripheral Artery Disease (AHA)
- Lipids and FH
- What is Cholesterol (ACC)
- What are High Blood Cholesterol and Triglycerides (AHA)
- How Do My Cholesterol Levels Affect My Risk (AHA)
- Managing High Cholesterol (ACC)
- Familial Hypercholesterolemia (FHF)
- Do You Know FH (FHF)
- Familial Hypercholesterolemia What to Expect: Treatment (FHF)
- Shared Decision Making for Familial Hypercholesteremia (FHF)
- What’s in My Family Tree (FHF)
- Heart Failure
- What is Heart Failure? (ACC)
- What is Heart Failure? (AHA)
- Turning Heart Failure into Heart Success (ACC)
- HF and Your Ejection Fraction Explained (AHA)
- How Can I Live with Heart Failure? (AHA)
- How Can I Improve My Low Ejection Fraction? (AHA)
- Heart Failure: Partnering in Your Treatment (AHA)
- Diabetes Basics
- T2DM Risk Assessment (ADA)
- Diabetes Symptoms and Tests for Diagnosis ADA)
- What Is Diabetes? (ADA)
- Type 2 Diabetes (ADA)
- What is Type 2 Diabetes (ACC)
- Type 1 Diabetes (ADA)
- Prediabetes (ADA)
- A1C (ADA)
- Factors Affecting Blood Glucose (ADA)
- Standards of Care (ADA)
- Diabetes Self-Management
- Managing Your Diabetes Starts with Education (AHA-ADA-KDBH)
- Checking Blood Glucose (ADA)
- Tracking Blood Glucose (ADA)
- Monitoring (ADCES)
- Glucose Monitoring: What’s in it for me? (ADCES)
- Glucose Monitoring: Insider Tips and Tricks (ADCES)
- Learning How to Inject Insulin (ADCES)
- Pro Tips (and Tricks) for Easier and Better Insulin Injections (ADCES)
- Libre: FreeStyle LibreLink App (Abbott)
- Libre: Remotely Share Glucose Data from Reader (Abbott)
- Libre: Sensor Application and Adhesion Guide (Abbott)
- Libre: Sharing Glucose Data with Your Doctor – LibreLink and LibreView Options (Abbott)
- Managing Blood Sugar with Time-in-Range (ADCES)
- Quick Guide to Simple Bolus (Omnipod)
- Preventing Complications of Diabetes
- Hypoglycemia (ADA)
- Managing Low Blood Sugar (ADCES)
- High Blood Sugar (Cornerstone4Care)
- Reducing Risks (ADCES)
- Nerve Damage and Diabetes (ADA)
- Autonomic Neuropathy (ADA)
- Peripheral Neuropathy (ADA)
- Taking Care of Your Feet (ADA)
- Skin Care and Infections (ADA)
- Kidney Disease: Signs and Treatment (ADA)
- Diabetes and Kidney Disease (ADA)
- T2DM and CKD (AHA-ADA-KDBH)
- Preventing or Delaying Kidney Disease (ADA)
- Diabetes and Oral Health (ADA)
- Eye Exams for People with Diabetes (ADA)
- Preparing for a Visit to Your Eye Doctor (ADA)
- Common Diabetic Eye Diseases (ADA)
- Sexuality and Diabetes (ADCES)
- T2DM and PAD (AHA-ADA-KDBH)
- HHS – Hyperglycemic Hyperosmolar Syndrome (ADCES)
- DKA – Diabetic Ketoacidosis (ADCES)
- Have Diabetes, Will Travel (ADCES)
- Managing Diabetes Safely During Sick Days (Cornerstone4Care)
- Managing Sick Days (CDC)
- Sick-Day Rules for Managing Diabetes (ADA)
- Sick Days, COVID-19 and Diabetes (Diabetes Education Services)
- Cardiometabolic Disease: Connecting T2DM and Heart Disease
- Heart Disease and Diabetes – Prevention (ADCES)
- Heart Disease and Diabetes – What is the Link (ADCES)
- Heart Disease and Diabetes – Top 5 Questions for Your Diabetes Team (ADCES)
- Heart Disease and Diabetes – Targets of Care (ADCES)
- Diabetes and Heart Disease Risk (ACC)
- Diabetes and Heart Disease (ADA)
- 4 Questions to Ask Your Health Care Provider About Diabetes and Your Heart (AHA-ADA-KDBH)
- T2DM and PAD (AHA-ADA-KDBH)
- Obesity and Weight Management
- Understanding Obesity and Severe Obesity (OAC)
- Understanding Excess Weight and its Role in Type 2 Diabetes (OAC)
- Obesity and Heart Disease (ACC)
- Obesity and Heart Disease Fact Sheet (OAC)
- Obesity and Lipid Abnormalities Fact Sheet (OAC)
- Obesity and Stroke Fact Sheet (OAC)
- Obesity and Hypertension Fact Sheet (OAC)
- Understanding Your Weight Loss Options (OAC)
- Weight Management: 10 Keys to Success (TOS)
- How Much Weight Do I Need to Lose? (TOS)
- Dietary Supplements for Weight Loss…What You need to Know (TOS)
- Is Weight Loss Surgery Right For You? (TOS)
- Healthy Eating
- Eat Right (AND)
- Eat Right on a Budget (AND)
- Healthy Eating (ADCES)
- How Do I Follow a Healthy Diet Pattern? (AHA)
- How Do I Understand the “Nutrition Facts” Label? (AHA)
- Weight Loss Tips (AND)
- Weight Management Cooking Tips (AND)
- Eat More, Weigh Less – How to Manage Your Weight Without Being Hungry (CDC)
- How to Avoid Portion Size Pitfalls to Help Manage Your Weight (CDC)
- How to Use Fruits and Vegetables to Help Manage Your Weight (CDC)
- Rethink Your Drink (CDC)
- Sugars and Sweeteners (ACC)
- Carbohydrate Counting for People with Diabetes (AND)
- Diabetes Label Reading Tips (AND)
- Type 2 Diabetes Nutrition Therapy (AND)
- Portion Control Placement (ADA)
- Heart-Healthy Nutrition (ACC)
- Cholesterol-Lowering Nutrition Therapy (AND)
- Heart Healthy Consistent Carbohydrate Nutrition Therapy (AND)
- A Week with the DASH Eating Plan (NIH)
- Worth Its Salt? (ACC)
- Fluid-Restricted Diet (AND)
- Heart Failure Nutrition Therapy (AND)
- Diabetes and CKD Stages 1-4 Nutrition Guidelines (AND)
- Physical Activity
- Why Should I be Physically Active? (AHA)
- How Can Physical Activity Become a Way of Life? (AHA)
- Being Active (ADCES)
- Active and Mindful Living (ACC)
- Physical Activity (ADA)
- Getting Started with Physical (ADA)
- Starter Walking Plan (ADA)
- Desk Moves (ADA)
- Aerobic, Resistance, Balance, and Flexibility Exercises (ADA)
- Tobacco Cessation
- All About Quitting Smoking (ADA)
- How Can I Quit Smoking? (AHA)
- Stop Smoking (ACC)
- How Can I Handle the Stress of Not Smoking? (AHA)
- How Can I Avoid Weight Gain When I Stop Smoking? (AHA)
- Goal Setting and Shared Decision-Making
- Problem Solving (ADCES)
- Small Steps for Your Health (ADA)
- Strategies Proven to Help People Eat Healthier and Exercise More (TOS)
- Shared Decision-Making (ACC)
- Mental and Emotional Well-Being
- How Can I Manage Stress? (AHA)
- Healthy Coping (ADCES)
- Diabetes and Your Emotional Well Being (ADA)
- Diabetes and Stress (ADA)
- Diabetes and Depression (ADA)
- Anger and Its Emotional Buddies (ADCES)
- Stress and a Little Something for All of Us (ADCES)
- Diabetes and Depression – Double Trouble (ADCES)
- Diabetes Distress – Dealing with the Weight of Diabetes (ADCES)
- Health Management Technology
- Top Recommended Diabetes Apps (Diabetes Education Services)
- Using Technology to Help Manage Medication Reminders (AAHFN)
- HF Path (AHA)
- Diabetes Food Hub (ADA)
- Tracking Tools
- How Can I Monitor My Cholesterol, Blood Pressure and Weight? (AHA)
- How Can I Keep Track of Physical Activity and Healthy Eating? (AHA)
- Food and Activity Tracker (ADA)
- Blood Pressure, Blood Glucose and Weight Log (CMCA)
- Self-Check Plan for HF Management (AHA)
- Warfarin Action Plan (CMCA)
- Preparing for Your Appointment
- Getting the Most Out of Health Care Visits (ADA)
- Standards of Care (ADA)
- Preparing for a Telemedicine Appointment (CMCA)
- Medication Information
- Taking Medications (ADCES)
- Tips for Improving Your Medication Taking (ADCES)
- Using Technology to Help Manage Medication Reminders (AAHFN)
- How Do I Manage My Medicines? (AHA)
- Diabetes and Heart Disease – Medication and Lifestyle Changes (ACC)
- Your Take Control Guide – Cardiometabolic Medications (ADA)
- Understanding Your Medications (AHA-ADA-KDBH)
- Understanding GLP-1 Receptor Agonists (ADCES)
- Using GLP-1 Receptor Agonists (ADCES)
- What to Know About GLP-1ra (CMCA)
- What to Know About SGLT2i (CMCA)
- What Is High Blood Pressure Medicine? (AHA)
- What Are Cholesterol-Lowering Medications? (AHA)
- What Are Anticoagulants and Antiplatelet Agents? (AHA)
- What Are Direct-Acting Oral Anticoagulants (DOACs)? (AHA)
- What Is Dual Antiplatelet Therapy (DAPT)? (AHA)
- Learning How to Inject Insulin (ADCES)
- Pro Tips (and Tricks) for Easier and Better Insulin Injections (ADCES)
- Understanding Insulin (ADCES)
- A Decision Aid for RAS Inhibitor Drug Options for Patients with Heart Failure (ACC)
- COVID-19 and Managing Chronic Disease
- COVID-19 and People with Certain Medical Conditions (CDC)
- Diabetes and Coronavirus (ADA)
- ACC’s COVID-19 Hub (ACC)
- COVID-19 and heart health – information for all (AHA)
- Cardiometabolic Disease: Connecting T2DM and Heart Disease
- Type 2 Diabetes and Cardiovascular Risk Toolkit (ACC)
- Know Diabetes by Heart: Professionals (AHA-ADA-KDBH)
- Webinars:
- Webinar 1: Translating Guidelines into Practice
- Webinar 2: Supporting Your Patients in Managing their CV Risk through Lifestyle Management
- Webinar 3: Managing Patients with Type 2 Diabetes: Approaches for Screening, Complication Management, and Treatment
- Webinar 4: Management of Type 2 Diabetes and Hypertension
- Webinar 5: Complex Cases in the Management and Treatment of Patients with T2D and High CVD Risk
- Webinar 6: Maximizing Patient outcomes: Navigating Common Barriers to Diabetes Treatment and Adherence
- Webinar 7: Overcoming Barriers to DSMES Referral and Treatment
- Podcasts:
- Know Diabetes by Heart Initiative Discussion
- Management and Treatment of Diabetes to Prevent Cardiovascular Disease
- American Heart Association’s 2018 Cholesterol Guidelines and the Implications for Type 2 Diabetes
- Shared Decision-Making
- ASCVD Risk Calculator
- Diabetes and Heart Failure
- Benefits of Diabetes Educator Referrals
- Use of Anti-hyperglycemic Agents with CVD Benefits
- Role of Cardiologist in Treatment of T2D and CVD Risk Management
- Lifestyle Management for Prevention of CVD
- American Diabetes Association’s 2020 Standards of Care and Implications for Practice
- The Patient Journey
- COVID-19 – Implications in the Management of Patients with T2D and CVD
- Heart Failure Management in Patients with T2D and CVD
- Identifying and Managing Renal Complications in Patients with T2D and CVD
- Clinical Management of Stable Coronary Artery Disease in Patients with T2D
- Evolving Care with COVID-19 for T2D Patients: Management, Telemedicine and Lessons Learned
- Online Learning Catalog (ACC):
- Fundamentals of SGLT2i’s and GLP-1RA’s for CV Risk
- Cardiovascular Risk in Diabetes: Applying Emerging Science to Practice
- Optimizing Lipid Lowering Strategies: Navigating the Evolving Landscape
- Follow the Science: Refining Risk Assessment in ASCVD
- PCSK9 Inhibitors: The What, How and Wow!
- Practice Tips for Prior Authorizations: A Discussion with the Experts
- Transforming LDL-C Risk: Role of Non-statin Therapies
- Intensification of LDL-C Lowering Therapies: Identifying the Very High-Risk Patient
- Raising Awareness and Understanding of Hypertrophic Cardiomyopathy
- Cardiovascular Care Coordinator Review Course
- Diabetes e-Learning (EASD):
- Management of Hyperglycemia in Type 2 Diabetes – ADA/EASD Consensus Report (2018) and Update (2019)
- SGLT-2 Inhibitors
- Cardiovascular Health and Diabetes
- Diabetic Foot Disease
- Diabetes and the Kidney
- Phenotypic Variability in Type 2 Diabetes
- Diabetic Ketoacidosis
- Diabetes and Ramadan
- Diagnosis of Type 1 Diabetes
- Technology and Type 1 Diabetes
- The Pathogenesis of Type 1 Diabetes
- Time in Range
- Adjunct Therapies
- Making the Connection: Virtual Edition (TCOYD)
- Heart Failure
- COVID-19 and Chronic Disease Management
- Practical Guide for Management of COVID-19 & Type 2 Diabetes (AHA-ADA-KDBH)
- COVID-19 Webinar Series (ADA)
- Real-World Cases – Inpatient Care for People with Diabetes and COVID-19
- COVID-19 and Advocacy
- Caring for your Patients with Diabetes Who Recently Have Been Unemployed due to COVID-19
- Updates – Diabetes Technology and COVID-19
- COVID-19 and the Diabetes Care Team: Challenges and Opportunities to Help Vulnerable Populations
- COVID-19 and Cardiovascular Concerns
- Managing Older Adults with Diabetes and COVID-19
- Planning Sick Days for Your Patients During COVID-19
- Telehealth and COVID-19
- Continuous Glucose Monitors
- Professional Continuous Glucose Monitoring Implementation Playbook (ADCES)
- Abbott FreeStyle Libre for Healthcare Professionals
- Dexcom G6 CGM for Healthcare Professionals
- Cost-Saving Resources
- Prescription Affordability Resources (CMCA)
- Insulin Cost-Saving Resource Guide (ADCES)
- Non-Insulin Diabetes Medication Cost-Saving Resource Guide (ADCES)
- Patient Assistance Guide (PhRMA)
- 10 Tips to Help Patients Afford Their Medications (ADCES)
- Exception and Appeals (Diabetes Access Ahead)
- Access to Innovative Medicines (PCNA)
- Health Literacy and Language
- Agency for Healthcare Research and Quality Health Literacy Universal Precautions Toolkit (AHRQ)
- Patient Education Materials Assessment Tool for Printable Materials (AHRQ)
- Speaking the Language of Diabetes (ADCES): PDF
- Weight Bias in Healthcare (OAC): PDF
- Understanding Obesity Stigma (OAC): PDF
- Implementation Guides
- Care Management: An Implementation Guide for Primary Care Practices (AHRQ)
- TeamSTEPPS 2.0: Strategies and Tools to Enhance Performance and Patient Safety (AHRQ)
- The Academy: Integrating Behavioral Health and Primary Care (AHRQ)
- Health Screening
- Risk Assessment Tools and Health Screening Instruments Commonly Used in Cardiometabolic Patients (CMCA)
- Health Screening Instruments (CMCA)
- Tools to Face the Psychological Demands of Diabetes (Behavioral Diabetes Institute)
- Addressing Food Insecurity in Health Care Settings (Feeding America)
- Hunger & Health: Get Help Finding Food Assistance (Feeding America)
- Find Your Local Food Bank (Feeding America)
- Health, Well-being and Dignity (Health Leads)
- Social Interventions Research & Evaluation Network (UCSF)
- Professional Mobile Applications
- A1CVD Pro App (AHA-ADA-KDBH)
- Standards of Care App (ADA)
- Guidelines on-the-go Mobile App (AHA)
- Mobile Resources (ACC): Guideline Clinical App, LDC-C Manager, Statin Intolerance App, TreatHF, ASCVD Risk Estimator Plus, AnticoagEvaluator, ManageAnticoag, CardioSmart Heart Explorer
- Pocket Guidelines App (ESC)
- Diabetes Self-Management Education and Support
- Diabetes Self-Management Assessment Tool (CMCA)
- Engaging Patients in Diabetes Self-Management (CMCA)
- DSMES Services (AHA-ADA-KDBH)
- DSMES Referral Form (AHA-ADA-KDBH)
- Medication Pocket Card: Common Oral Diabetes Meds (Diabetes Education Services)
- Medication Pocket Card: Other Oral Diabetes Meds (Diabetes Education Services)
- Medication Pocket Card: GLP-1ra and Injectables (Diabetes Education Services)
- Medication Pocket Card: Insulin (Diabetes Education Services)
- Prescribing Insulin and Diabetes Supplies: Quick Reference (CMCA)
- Addressing Core Defects of T2DM with Targeted Pharmacotherapy (CMCA)
- Teaching Patients Self-Management Skills
- Diabetes Care and Education Specialist: Basic Certificate (ADCES)
- Diabetes Paraprofessional Level 2 (ADCES)
- Innovating Decisions and Empowering Action in Diabetes Management (ADCES)
- Health Educator’s Nutrition Toolkit: Setting the Table for Healthy Eating (FDA)
- Glucose Monitoring: Expert Recommendations (ADCES)
- Glucose Monitoring: Turning Information into Insight (ADCES)
- Shared Decision-Making Discussion Guide (AHA-ADA-KDBH)
- Warfarin Action Plan (CMCA)
- Helping Diabetes Educators Care for Patients with Kidney Disease (NIDDK)
- Module 1: Identify Diabetic Kidney Disease
- Module 2: Slowing Progression of Kidney Disease
- Module 3: Complications
- Module 4: Kidney Failure Treatment, Patient Education, and Course Summary
- Engaging the Disengaged Patient: Strategies for Successful Diabetes Self-Management (NIDDK)
- Motivational Interviewing: Do’s and Don’ts (NIDDK)
- Less Talk, More Listening: Improved Diabetes Outcomes (NIDDK)
- Support for Behavior Change (NIDDK)
- Excess Weight and Your Health (OAC)
- Consumer Guides (Diabetes Forecast-ADA)
- Blood Glucose Meters (ADA)
- Continuous Glucose Monitors (ADA)
- Glucose Products (ADA)
- Insulin Pens (ADA)
- Medications (ADA)
- Online Learning (PCNA)
- Connecting Diabetes and Heart Disease
- Effective Strategies for Engaging Patients in Health Behavior Change
- Heart Failure – Improving Patient Outcomes
- Cardiorenal Syndrome: Managing Risk and Treating Disease
- Cardiovascular Disease Risk Stratification
- Interpreting and Translating Research into Practice
- Latest in Lipid Treatment Guidelines and Challenges
- Pharmacological and Surgical Management for Weight Loss
- New Year, New Hypertension Guidelines
- Lower Extremity PAD: How to Help Your Patients Get Back on Their Feet
- Cardiovascular Risk Reduction and LDL-C: Evolving Perspectives
- Big Data and the Future of Cardiovascular Disease Prevention and Treatment
- Integrating Sleep Assessments and Treatments in Your CVD Practice
- Managing CVD Risks in Older Adults: Lessons from a Geriatric Cardiology Practice
- Case Studies in Cardiovascular Risk Reduction with non-Statin Therapies: Rapid Fire Roundtable
- Heart Failure Nurse Talking Tip Sheets
- Heart Failure Complicated by Cardiorenal Syndrome (AAHFN)
- Motivational Techniques to Promote Patient Exercise and Activity (AAHFN)
- Heart Failure with a Preserved Ejection Fraction (AAHFN)
- Guiding Your Patient’s Exercise Routine (AAHFN)
- Practice Management and Implementation Videos
- Welcome and Overview
- Navigating CMCA Resources and Tools
- Paving a Path for Success
- Change Package: Part 1
- Patient Care and Team Workflows
- Clinical Education Videos
- Optimizing Care in Cardiometabolic Disease
- GLP-1 Receptor Agonists as Guidelines Directed Medical Therapy
- SGLT2 Inhibitors as Guidelines Directed Medical Therapy
- Physiology of Glucose Regulation
- Insulin Resistance and the Progression to T2DM